#$%^&*AU2018226514A120180927.pdf#####ABSTRACT The present disclosure provides methods of treating or preventing respiratory condition and/or for treating an IgE-mediated allergy and/or for reducing an allergic response to an allergen and/or for inducing anergy to an allergen in a subject and/or improving lung function in a subject suffering from an allergy comprising administering to a subject a population of cells enriched for STRO-1l cells and/or progeny thereof and/or soluble factors derived therefrom.